A Study to Investigate the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injections of PG-102 (MG12) in Healthy Adult and Obesity Participants.
Clinical trial NCT06309667 · COMPLETED
Trial details
- NCT number
- NCT06309667
- Sponsor
- ProGen. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-04
- Primary completion
- 2025-02-05
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.